Hi Laura,
Thanks! Yes, 1-1-11 started on a good note. Considering that Biogen-IDEK has successfully marketed immunotherapeutics for cancer, I hope they can do the same for a PD vaccine.
Girija
Quote:
Originally Posted by Conductor71
Well, I don't know about anyone else, but when I read this news; I thought it's only day 1 of the new year and already life is better!
Affiris sold the patent rights to Biogen for its PD vaccine for a cool $427 mill.
Bioworld Article
The vaccine aims to stop the alpha-synuclein protein from misbehaving. It has halted disease process in animal models. While this is not a cure, with something like PD that most likely has several different origins, it would be highly unlikely a one size fits all cure might be found. This is the first time ever that a treatment targets the cause of the disease. Meanwhile, the U of Nebraska is onto this but is struggling to find a pharmaceutical partner...
Well, I seem to be the only one excited by this lately but just wanted to share anyway.
Laura |